| Primary |
| Epilepsy |
29.6% |
| Lennox-gastaut Syndrome |
21.0% |
| Constipation |
6.2% |
| Convulsion |
6.2% |
| Nausea |
4.9% |
| Sepsis |
4.9% |
| Acidosis |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Hypoxia |
2.5% |
| Infantile Spasms |
2.5% |
| Myoclonic Epilepsy |
2.5% |
| Respiratory Distress |
2.5% |
| Status Epilepticus |
2.5% |
| Vagal Nerve Stimulator Implantation |
2.5% |
| Complex Partial Seizures |
1.2% |
| Menorrhagia |
1.2% |
| Orthostatic Hypotension |
1.2% |
| Osteoporosis |
1.2% |
| Pancreatitis |
1.2% |
| Petit Mal Epilepsy |
1.2% |
|
| Vomiting |
12.5% |
| Rash |
10.4% |
| Liver Function Test Abnormal |
6.3% |
| Paranoia |
6.3% |
| Psychotic Disorder |
6.3% |
| Sudden Unexplained Death In Epilepsy |
6.3% |
| Agitation |
4.2% |
| Blood Potassium Decreased |
4.2% |
| Convulsion |
4.2% |
| Death |
4.2% |
| Dehydration |
4.2% |
| Headache |
4.2% |
| Lethargy |
4.2% |
| Rash Maculo-papular |
4.2% |
| Somnolence |
4.2% |
| Speech Disorder |
4.2% |
| Weight Decreased |
4.2% |
| Aggression |
2.1% |
| Aphasia |
2.1% |
| Chorea |
2.1% |
|
| Secondary |
| Epilepsy |
29.4% |
| Lennox-gastaut Syndrome |
19.6% |
| Constipation |
12.7% |
| Convulsion |
4.9% |
| Nausea |
3.9% |
| Seizures |
3.9% |
| Sepsis |
3.9% |
| Product Used For Unknown Indication |
2.9% |
| Status Epilepticus |
2.9% |
| Acidosis |
2.0% |
| Hypoxia |
2.0% |
| Infantile Spasms |
2.0% |
| Myoclonic Epilepsy |
2.0% |
| Respiratory Distress |
2.0% |
| Urinary Tract Infection |
2.0% |
| Vagal Nerve Stimulator Implantation |
2.0% |
| Drug Use For Unknown Indication |
1.0% |
| Seizure |
1.0% |
|
| Vomiting |
22.4% |
| Somnolence |
10.4% |
| Death |
9.0% |
| Paranoia |
9.0% |
| Chorea |
4.5% |
| Convulsion |
4.5% |
| Nephrotic Syndrome |
4.5% |
| Psychotic Disorder |
4.5% |
| Speech Disorder |
4.5% |
| Sudden Unexplained Death In Epilepsy |
4.5% |
| Oropharyngeal Pain |
3.0% |
| Product Substitution Issue |
3.0% |
| Rash Maculo-papular |
3.0% |
| Status Epilepticus |
3.0% |
| Weight Decreased |
3.0% |
| Abnormal Behaviour |
1.5% |
| Aphasia |
1.5% |
| Crying |
1.5% |
| Dehydration |
1.5% |
| Dizziness |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.0% |
| Epilepsy |
20.6% |
| Convulsion |
14.6% |
| Complex Partial Seizures |
6.0% |
| Lennox-gastaut Syndrome |
4.8% |
| Insomnia |
2.6% |
| Anxiety |
2.4% |
| Generalised Oedema |
2.2% |
| Infantile Spasms |
2.2% |
| Attention Deficit/hyperactivity Disorder |
1.7% |
| Sleep Disorder |
1.5% |
| Hypokalaemia |
1.4% |
| Nutritional Supplementation |
1.4% |
| Pyrexia |
1.0% |
| Constipation |
0.9% |
| Upper Respiratory Tract Infection |
0.9% |
| Grand Mal Convulsion |
0.7% |
| Mineral Supplementation |
0.7% |
| Nasal Discomfort |
0.7% |
| Quadriplegia |
0.7% |
|
| Convulsion |
30.4% |
| Status Epilepticus |
14.3% |
| Dehydration |
7.1% |
| Rash Pruritic |
5.4% |
| Screaming |
5.4% |
| Somnolence |
5.4% |
| Urinary Tract Infection |
5.4% |
| Product Substitution Issue |
3.6% |
| Right Ventricular Hypertrophy |
3.6% |
| Abdominal Pain |
1.8% |
| Abnormal Behaviour |
1.8% |
| Adverse Event |
1.8% |
| Aggression |
1.8% |
| Atonic Seizures |
1.8% |
| Coagulation Time Prolonged |
1.8% |
| Crying |
1.8% |
| Dizziness |
1.8% |
| Drug Dose Omission |
1.8% |
| Drug Effect Decreased |
1.8% |
| Drug Ineffective |
1.8% |
|
